James Mitchell
Corporate Officer/Principal chez PAVMED INC.
Postes actifs de James Mitchell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| PAVMED INC. | Corporate Officer/Principal | 01/06/2021 | - |
Oncodisc, Inc.
 Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Directeur Général | 01/01/2018 | - |
| Fondateur | 01/01/2018 | - |
Historique de carrière de James Mitchell
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Technology Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PAVMED INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Oncodisc, Inc.
Oncodisc, Inc. Internet Software/ServicesTechnology Services Part of PAVmed, Inc., Oncodisc, Inc. is a company that is developing the Oncodisc Remote Care Platform (Oncodisc RCP) to personalize care through remote detection of changes in patient health status and enhance doctor-patient communication. The company is based in Walnut Creek, CA. Oncodisc (now Veris Health) is developing data-driven remote care technology designed to benefit cancer and chronic disease patients by providing artificial intelligence-embedded, physician-designed software integrated with intelligent vascular access technology. The company was founded in 2018 by James Mitchell and Andrew Thoreson, and James Mitchell has been the CEO since then. The company was acquired by Veris Health, Inc. from Oncodisc Holdings LLC on June 02, 2021 for $0.16 million. | Technology Services |
- Bourse
- Insiders
- James Mitchell
- Expérience
